Juno specializes in bringing complex and high value generic and biosimilar products to the Canadian market and providing meaningful cost savings to strained healthcare budgets across the country.
The Juno management team possesses decades of pharmaceutical industry experience along with an extensive track record of driving strategic growth through the identification of niche products and disciplined construction of robust product pipelines.
An early member of the global Juno Pharmaceuticals group, Juno’s global operations span four continents and consist of over 10 diverse specialty pharmaceutical businesses collectively generating over $300 million in annual sales and spread across Canada, the United Kingdom, the European Union, Australia and South Africa.
Juno specializes in bringing complex and high value generic and biosimilar products to the Canadian market and providing meaningful cost savings to strained healthcare supply chains and budgets across the country.
The Juno management team possesses decades of pharmaceutical industry experience along with an extensive track record of driving strategic growth through the identification of niche products and disciplined construction of robust product pipelines.
An early member of the global Juno Pharmaceuticals group, Juno’s global operations span four continents and consist of over 15 diverse specialty pharmaceutical businesses collectively generating over $600 million in annual sales and spread across Canada, the United Kingdom, the European Union, Australia and South Africa.
